Twelve-Month Frequency of Drug-Metabolizing Enzyme and Transporter-Based Drug-Drug Interaction Potential in Patients Receiving Oral Enzyme-Targeted Kinase Inhibitor Antineoplastic Agents
Authors:
- Steven J. BowlinSBSteven J. Bowlin
- Fang XiaFXFang Xia
- Wenyi WangWWWenyi Wang
- Keisha D. RobinsonKRKeisha D. Robinson
- Eric J. StanekESEric J. Stanek
- 1 February 2013
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 88 (2) , 139-148
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Potential drug interactions in elderly cancer patientsCritical Reviews in Oncology/Hematology, 2011
- Potential drug interactions in cancer therapy: a prevalence study using an advanced screening methodAnnals of Oncology, 2011
- Potential drug–drug interactions between anti-cancer agents and community pharmacy dispensed drugsPharmacy World & Science, 2010
- The treatment of co-morbidities in older patients with metastatic cancerSupportive Care in Cancer, 2010
- Frequency and nature of drug–drug interactions in a Dutch university hospitalBritish Journal of Clinical Pharmacology, 2009
- Medication Problems in Older, Newly Diagnosed Cancer Patients in Canada: How Common are They?Drugs & Aging, 2009
- Potential Drug Interactions in Cancer Patients Receiving Supportive Care ExclusivelyJournal of Pain and Symptom Management, 2008
- Potential Drug Interactions and Duplicate Prescriptions Among Cancer PatientsJNCI: Journal of the National Cancer Institute, 2007
- Potential for drug interactions in hospitalized cancer patientsCancer Chemotherapy and Pharmacology, 2005
- A guide to clinically relevant drug interactions in oncologyJournal of Oncology Pharmacy Practice, 2003